Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Merck
Baxter
Mallinckrodt
AstraZeneca

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Perrigo R And D Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for PERRIGO R AND D, and what generic and branded alternatives to PERRIGO R AND D drugs are available?

PERRIGO R AND D has forty-two approved drugs.



Summary for Perrigo R And D
US Patents:0
Tradenames:26
Ingredients:23
NDAs:42

Drugs and US Patents for Perrigo R And D

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo R And D CETIRIZINE HYDROCHLORIDE HIVES cetirizine hydrochloride TABLET;ORAL 078336-003 Dec 27, 2007 OTC No No   Start Trial   Start Trial
Perrigo R And D RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 091429-001 May 11, 2011 OTC No No   Start Trial   Start Trial
Perrigo R And D NICOTINE POLACRILEX nicotine polacrilex TROCHE/LOZENGE;ORAL 077007-002 Jan 31, 2006 OTC No No   Start Trial   Start Trial
Perrigo R And D NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE diphenhydramine hydrochloride; naproxen sodium TABLET;ORAL 208499-001 May 10, 2019 OTC No No   Start Trial   Start Trial
Perrigo R And D FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE calcium carbonate; famotidine; magnesium hydroxide TABLET, CHEWABLE;ORAL 077355-001 Feb 6, 2008 OTC No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Merck
Boehringer Ingelheim
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.